| Autor: |
Eswarachari V; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Kadam P; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Movva S; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Lingaiah S; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Akther RM; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Kidangan FX; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Gowda KC; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Golakoti RRK; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India., Lall M; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India., Mahajan S; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India., Saviour P; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India., Puri R; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India., Verma IC; Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India., Vedam RL; Medgenome Labs Ltd., Narayana Nethralaya, Bangalore, India. |
| Abstrakt: |
Introduction: Noninvasive prenatal testing (NIPT) is a reliable screening method for fetal aneuploidy detection of trisomy 18, 13, 21 along with few sex chromosome abnormalities monosomy X, XXX, XXY (Klinefelter), XYY (Jacob) syndromes and certain microdeletions which include cri-du-chat, DiGeorge, 1p36, Angelman, and Prader-Willi syndromes in comparison to the available screening methods. Prenatal screening of Turners syndrome is possible by ultrasound in certain conditions only. Recently benefits of early detection and treatment of Turners syndrome has been emphasized, enforcing on accurate and early screening prenatally. Case details: The current case emphasizes on the reliability of NIPT testing which comes with an advantage of early screening. A 24-year-old primi gravida was referred for NIPT as she tested for high risk on biochemical screening. The Panorama™ NIPT results showed low risk for trisomies, 21, 18, and 13 but high risk of monosomy X and was advised confirmatory amniocentesis. The fluorescence in situ hybridization (FISH) report revealed no numerical abnormality detected for any of the five chromosomes tested. On receiving this discordant report, the sample was rerun for NIPT, to rule out any laboratory-related issues. The result obtained on a rerun was consistent with the first report and showed monosomy X again. The karyotype report was available three weeks later and a rare variant of Turners syndrome was identified. Discussion: Panorama™ NIPT considers single nucleotide polymorphisms spread across the chromosomes for analysis, different variants of aneuploidy can be picked up in comparison to FISH, similar to the current case wherein it could not as it was a centromeric probe. Reported first case of X chromosome variant detected by NIPT confirmed by karyotyping, missed by FISH. |
